Re-initiation of anticoagulation after central nervous system hemorrhage during treatment with direct oral anticoagulants: a single hospital cohort study.
Senta FrolMišo ŠabovičJanja Pretnar OblakPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
In carefully selected patients, re-initiation of DOAC therapy did not increase the rate of both endpoints. Recommendations for DOAC re-initiation, which include hypertension and diabetes control, as well as treated vascular malformations, and excluded cerebral amyloid angiopathy, appear to be valid in clinical practice.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- clinical practice
- end stage renal disease
- newly diagnosed
- blood pressure
- ejection fraction
- cardiovascular disease
- chronic kidney disease
- prognostic factors
- stem cells
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- mesenchymal stem cells
- replacement therapy
- drug induced